×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
复旦大学上海医学院 [93]
内容类型
期刊论文 [70]
会议论文 [23]
发表日期
2019 [14]
2018 [10]
2017 [5]
2016 [19]
2015 [11]
2014 [7]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共93条,第1-10条
帮助
限定条件
专题:复旦大学上海医学院
第一署名单位
第一作者单位
通讯作者单位
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Adjuvant hormone therapy after radical prostatectomy in high-risk localized and locally advanced prostate cancer: First multicenter, observational study in China
期刊论文
CHINESE JOURNAL OF CANCER RESEARCH, 2019, 卷号: 31, 期号: 3
作者:
Huang, Yiran
;
Du, Chuanjun
;
Ye, Dingwei
;
Zhang, Wei
;
Ma, Lulin
收藏
  |  
浏览/下载:23/0
  |  
提交时间:2019/12/05
Adjuvant hormone therapy
combined androgen blockade
PSA recurrence
quality of life
radical prostatectomy
The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer
期刊论文
CANCER COMMUNICATIONS, 2019, 卷号: 39
作者:
Wang, Feng-Hua
;
Shen, Lin
;
Li, Jin
;
Zhou, Zhi-Wei
;
Liang, Han
收藏
  |  
浏览/下载:40/0
  |  
提交时间:2019/12/05
Chinese Society of Clinical Oncology (CSCO)
Gastric cancer
Diagnosis
Surgery
Neoadjuvant
Adjuvant
Radiotherapy
Chemotherapy
Targeted therapy
Immunotherapy
A phase 3 study of durvalumab with or without bevacizumab as adjuvant therapy in patients with hepatocellular carcinoma at high risk of recurrence after curative hepatic resection or ablation: EMERALD-2
会议论文
作者:
Knox, J.
;
Cheng, A.
;
Cleary, S.
;
Galle, P.
;
Kokudo, N.
收藏
  |  
浏览/下载:8/0
  |  
提交时间:2019/12/05
Evaluation of corneal cross-linking as adjuvant therapy for the management of fungal keratitis
期刊论文
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2019, 卷号: 257, 期号: 7
作者:
Wei, Anji
;
Wang, Kaidi
;
Wang, Yan
;
Gong, Lan
;
Xu, Jianjiang
收藏
  |  
浏览/下载:14/0
  |  
提交时间:2019/12/05
Corneal cross-linking
Fungal keratitis
Riboflavin
Ultraviolet A (UV-A)
The Unique Spatial-Temporal Treatment Failure Patterns of Adjuvant Gefitinib Therapy: A Post Hoc Analysis of the ADJUVANT Trial (CTONG 1104)
期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2019, 卷号: 14, 期号: 3
作者:
Xu, Song-Tao
;
Xi, Jun-Jie
;
Zhong, Wen-Zhao
;
Mao, Wei-Min
;
Wu, Lin
收藏
  |  
浏览/下载:36/0
  |  
提交时间:2019/12/05
NSCLC
EGFR
tyrosine kinase inhibitor
gefitinib
adjuvant chemotherapy
Predicting the Value of Adjuvant Therapy in Esophageal Squamous Cell Carcinoma by Combining the Total Number of Examined Lymph Nodes with the Positive Lymph Node Ratio
期刊论文
ANNALS OF SURGICAL ONCOLOGY, 2019, 卷号: 26, 期号: 8
作者:
Li, Yida
;
Zhao, Weixin
;
Ni, Jianjiao
;
Zou, Liqing
;
Yang, Xi
收藏
  |  
浏览/下载:26/0
  |  
提交时间:2019/12/05
Efficacy of adjuvant radiotherapy for atypical and anaplastic meningioma
期刊论文
CANCER MEDICINE, 2019, 卷号: 8, 期号: 1
作者:
Zhu, Hongda
;
Bi, Wenya Linda
;
Aizer, Ayal
;
Hua, Lingyang
;
Tian, Mi
收藏
  |  
浏览/下载:35/0
  |  
提交时间:2019/12/05
anaplastic meningioma
atypical meningioma
overall survival
progression-free survival
radiation therapy
Modified FOLFIRINOX for resected pancreatic cancer: Opportunities and challenges
期刊论文
WORLD JOURNAL OF GASTROENTEROLOGY, 2019, 卷号: 25, 期号: 23
作者:
Yang, Feng
;
Jin, Chen
;
Fu, De-Liang
;
Warshaw, Andrew L.
收藏
  |  
浏览/下载:17/0
  |  
提交时间:2019/12/05
Pancreatic cancer
Adjuvant therapy
FOLFIRINOX
Neutrophil-to-lymphocyte
Nanoliposomal irinotecan
Patterns of Use of Docetaxel-Containing Adjuvant Chemotherapy Among Chinese Patients with Operable Breast Cancer: A Multicenter Observational Study
期刊论文
ADVANCES IN THERAPY, 2019, 卷号: 36, 期号: 1
作者:
Xie, Hui
;
Liu, Jinping
;
Yu, Shiyou
;
Chen, Yiding
;
Zheng, Min
收藏
  |  
浏览/下载:41/0
  |  
提交时间:2019/12/05
Breast cancer
Docetaxel
G-CSF
Oncology
Real world
Treatment patterns
Fulvestrant 500 mg Versus Exemestane in Postmenopausal Women With Metastatic Breast Cancer Resistant to Adjuvant Nonsteroidal Aromatase Inhibitors in Clinical Practice: A Multicenter Retrospective Study
期刊论文
CLINICAL BREAST CANCER, 2019, 卷号: 19, 期号: 3
作者:
Xie, Yizhao
;
Li, Yi
;
Zhang, Yinbin
;
Zhang, Shuqun
;
Li, Wei
收藏
  |  
浏览/下载:26/0
  |  
提交时间:2019/12/05
ER+ HER2(-) breast cancer
Endocrine sensitivity
Endocrine therapy
Fulvestrant
Metastatic breast cancer
©版权所有 ©2017 CSpace - Powered by
CSpace